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doi:10.1Objective:Our objective was to determine whether regional visceral perfusion during neonatal aortic arch recon-
struction attenuates postoperative acute kidney injury.
Methods: A technique to provide simultaneous perfusion to the brain and viscera during aortic arch reconstruc-
tion in neonates was developed and applied (multisite perfusion). The effect of the technique on postoperative
renal function was assessed by comparing the incidence of acute kidney injury in neonates undergoing multisite
perfusion to a control group of neonates who underwent aortic arch reconstruction with regional cerebral perfu-
sion alone.
Results: Thirteen neonates underwent multisite perfusion during procedures involving reconstruction of the aor-
tic arch. Twenty-four neonates who underwent similar procedures with regional cerebral perfusion alone were
selected as controls. The incidence of acute kidney injury in those undergoing multisite perfusion was 8%
(n¼ 1), compared with 50% (n¼ 12) in the control group (P¼ .01). The median percentage change in estimated
creatinine clearance was 0 (33 toþ60) in the multisite perfusion group, compared with29 (50 toþ14) in the
control group (P< .01). Patients in the multisite perfusion group were less frequently exposed to preoperative
nephrotoxins and intraoperative aprotinin and had a higher prevalence of preoperative comorbidity, a shorter du-
ration of regional cerebral perfusion, and a longer length of stay in the intensive care unit.
Conclusions: Acute kidney injury is common after reconstruction of the aortic arch in neonates. By providing
direct visceral perfusion during surgery, this simple multisite perfusion technique may ameliorate acute kidney
injury in these neonates. Further investigation of this technique is warranted. (J Thorac Cardiovasc Surg
2010;140:453-8)Acute kidney injury (AKI) after surgery for congenital heart
disease performed with cardiopulmonary bypass (CPB) is
common and results in increased morbidity and mortality.1,2
The use of circulatory arrest with deep hypothermia during
repair of complex aortic arch obstruction in neonates
offers the advantage of a bloodless and unobstructed
surgical field at the expense of compounding the end-
organ injury initiated by CPB. The risk of neurologic injury
during circulatory arrest prompted several investigators to
develop regional cerebral perfusion (RCP) techniques to
minimize the period of cerebral circulatory arrest and result-
ing neurologic injury.3-5
Accumulating data from adults and children suggest that
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The Journal of Thoracic and Cadeephypothermia, despite the reduction in renalmetabolic de-
mand related to hypothermia.6-8 To reduce the potential for
renal ischemia during neonatal aortic arch reconstruction,
we developed and used a technique to provide simultaneous
regional visceral and cerebral perfusion. We hypothesized
that providing regional visceral perfusion during procedures
involving complex aortic arch reconstructions in neonates
would decrease the rate of postoperative AKI. We assessed
the efficacy of the new technique by comparing the
incidence of AKI after neonatal aortic arch surgery
performed with multisite perfusion (MSP) with that in
recent historic controls undergoing repair with RCP alone.P
MMETHODS
Enrollment Criteria
Thirteen neonates underwent neonatal aortic arch reconstruction using
MSP (group 1). The aortic arch repair was in addition to the following pro-
cedures: ventricular septal defect (VSD) closure (n ¼ 6), stage I Sano oper-
ation (n ¼ 5), pulmonary artery banding (n ¼ 1), and pulmonary artery
banding with mitral valvotomy (n ¼ 1). These 13 procedures were per-
formed by 2 congenital heart surgeons over a 7-month period in 2009.
Twenty-four consecutive control patients (12 having stage I Sano proce-
dures and 12 having relief of aortic arch obstruction with VSD repairs) were
used for comparison in this case–control study (group 2). These 24 proce-
dures were performed by 4 congenital heart surgeons from 2007 through
2009. Three otherwise eligible patients were excluded from the control
group because the need for mechanical support of the circulation with anrdiovascular Surgery c Volume 140, Number 2 453
TABLE 1. Baseline demographics of the study cohort
Variables
MSP
(n ¼ 13)
RCP only
(n ¼ 24) P value
Male 4 (31) 13 (54) .30
Weight (kg) 3.14 (2.20–4.20) 3.29 (2.06–4.50) .35
Prematurity 2 (15) 3 (13) 1.0
Comorbidity 7 (54) 4 (17) .03
Shock 0 (0) 1 (4) 1.0
Catheterization/contrast
exposure
1 (8) 4 (17) .64
Mechanical ventilation 2 (15) 7 (29) .45
Inotropes 6 (46) 9 (38) .73
Diuretics 9 (69) 16 (67) 1.0
Nephrotoxin exposure 0 (0) 8 (33) .03
Age at operation (d) 4 (2–10) 6 (2–18) .09
Preoperative ICU
length of stay (d)
4 (2–9) 4 (1–7) .65
eCCL (mL $ min1 $ 1.73 m2) 41 (18–60) 41 (23–89) .62
Data are reported as number (%) or median (minimum–maximum). MSP, Multisite
perfusion; RCP, retrograde cerebral perfusion; ICU, intensive care unit; eCCL, esti-
mated creatinine clearance.
Abbreviations and Acronyms
AKI ¼ acute kidney injury
CPB ¼ cardiopulmonary bypass
eCCL ¼ estimated creatinine clearance
MSP ¼ multisite perfusion
pRIFLE ¼ Pediatric Risk, Injury, Failure, Loss,
End Stage classification of acute
kidney injury
RCP ¼ regional cerebral perfusion
VSD ¼ ventricular septal defect
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Mextracorporeal membrane oxygenator within 72 hours of surgery obfuscated
their renal function. Only those procedures using RCP were selected as con-
trols to account for the low-grade somatic perfusion provided during RCP.9
Of the 37 patients in this study, 35 were discharged home and 2 are conva-
lescing in the hospital. This study was approved by the institutional review
board of the Children’s Hospital, Boston. Owing to the retrospective nature
of the data collection, the requirement for informed consent was waived.Surgical Technique
The standard technical approaches to these lesions were used, with minor
modifications. All procedures were performed through a median sternot-
omy. Cerebral perfusionwas achieved by cannulating a polytetrafluoroethy-
lene tube graft sewn end to side onto the innominate artery. Visceral
perfusion was provided through a 3F 3-cm femoral arterial catheter
(n¼ 9) or 3.5F 10-cm umbilical arterial catheter (n¼ 4). Selective coronary
perfusion was provided through a standard cardioplegia cannula placed into
the ascending aorta (n¼ 10). These 3 cannulas were connected to the arterial
perfusion limb of the CPB circuit. Venous drainage was obtained by single
or dual venous cannulation. CPB was initiated through the innominate ar-
tery shunt, and moderate (n¼ 9) or deep (n¼ 4) hypothermia was induced.
The left side of the heart was vented with a cannula placed through the right
upper pulmonary vein. MSP was initiated by isolation of the hypoplastic
aortic arch using tourniquets and clamps. CPB flow through the regional
cannulas was decreased to 80 to 100 ml $ kg1 $ min1. Circulatory arrest
with deep hypothermia was performed for delivery of cardioplegic solution
through the innominate artery shunt with clamping of the transverse aorta in
a subset of patients. Patients undergoing selective coronary perfusion (typ-
ically those with normal-sized aortic roots) had a clamp placed at the level of
the sinotubular junction, allowing the decompressed heart to beat during
aortic arch repair. The electrocardiogram was monitored carefully during
this period for any signs of ischemia.Definitions
The primary outcome for the study was the development of AKI within
72 hours of surgery. The immediate preoperative estimated creatinine clear-
ance (eCCL) and the 72-hour postoperative nadir eCCL were used to calcu-
late the percent change in renal function. The percent change in renal
function was also determined using the immediate preoperative eCCL and
the mean 72-hour postoperative eCCL. In accordance with the Pediatric
Risk, Injury, Failure, Loss, End Stage classification of acute kidney injury
(pRIFLE) AKI staging system, a greater than 25% decrease in the eCCL
was used as the threshold to define AKI.10 Given that we characterized post-
operative renal function by 2 different methods, we report the prevalence of
AKI using both definitions (AKIpostop nadir and AKIpostop mean).
The eCCL was calculated using the Schwartz formula (k $ height [cm]/
plasma creatinine [mg/dL]). The constant k was 0.33 for infants born at less
than 38 weeks’ gestation and 0.45 for those born at or after 38 weeks’ ges-454 The Journal of Thoracic and Cardiovascular Surgtation.11,12 The pRIFLE criteria for AKI can also be met by oliguria (<0.5
mL $ kg1 $ h1 for 8 hours), but no patient in our studymet this definition.
We chose the pRIFLE criteria for AKI and not the definition recently put
forth by the Society of Thoracic Surgeons and the Multi-Societal Database
Committee for Pediatric and Congenital Heart Disease (doubling of preop-
erative creatinine) inasmuch as this definition is insensitive to clinically im-
portant derangements in renal function.13
Prematurity was defined as birth at less than 38weeks of gestation. Shock
was defined as the need for resuscitation with inotropes and/or volume ex-
pansion, with the development of brain, liver, or kidney dysfunction in the
setting of a closing ductus arteriousus or a restrictive atrial septal communi-
cation. The binary categorical variable, ‘‘comorbidity,’’ was created to ac-
count for any preoperative condition with the potential to affect the
postoperative course and/or postoperative renal function (single or dysplas-
tic kidney, genetic syndrome, major malformation, and so on). Similarly, the
presence or absence of ‘‘residual anatomic disease’’ with the potential to af-
fect renal function or postoperative course was abstracted from the available
data (ie, residual VSD or aortic arch obstruction). Deep hypothermiawas de-
fined as an intraoperative core body temperature of less than 19C. The ino-
trope score was calculated for each hour after surgery, as follows: dopamine
(mg $ kg1 $min1)þdobutamine (mg $ kg1 $min1)þmilrinone $ 10 (mg $
kg1 $ min1)þepinephrine $ 100 (mg $ kg1 $ min1).14 The peak inotrope
score for each postoperative day was then recorded. The day of surgery was
postoperative day 0.
Statistical Analysis
SPSS version 15.0 software (SPSS, Inc, Chicago, Ill) was used for data
analysis. Continuous, nonnormally distributed data were compared by the
Wilcoxon rank sum test, and categorical data were analyzed by Fisher’s ex-
act test.RESULTS
The baseline demographics of the 2 groups were statisti-
cally similar, with some notable exceptions (Table 1). A
greater percentage of patients undergoing MSP had comor-
bid conditions at the time surgery compared with controls
(54% vs 17%). The most common comorbidities in both
groups were recognized genetic syndromes and grossery c August 2010
TABLE 2. Intraoperative variables
Variable
MSP
(n ¼ 13)
RCP only
(n ¼ 24) P value
Procedure .73
Stage I with Sano
modification
5 (39) 12 (50)
Aortic arch reconstruction
with additional procedure
8 (62) 12 (50)
Perfusion times (min)
CPB time 142 (60–185) 139 (110–254) .99
Cross clamp time 66 (0–115) 60 (22–125) .76
Circulatory arrest time 0 (0–32) 3 (0–46) .40
RCP time 34 (14–54) 43 (19–68) .03
Regional abdominal
perfusion time
34 (14–54) NA NA
Temperature nadir (C) 26 (14.7–32) 17.8 (13.2–32) .26
Circulation arrested 4 (31) 12 (50) .32
Hematocrit nadir (g/dL) 29.0 (27.0–34.0) 29.0 (22.0–32.0) .95
Peak intraoperative
lactate (mmol/L)
6.3 (2.7–8.8) 6.0 (2.7–12.6) .63
Aprotinin 0 (0) 7 (29) .04
Tranexamic acid 12 (92) 5 (21) <.01
Urine output
(mL $ kg1 $ h1)*
2.3 (1.1–6.3) 3.1 (.8–11.6) .52
Delayed sternal closure 10 (77) 14 (58) .31
Peritoneal drain placement 0 (0) 3 (13) .54
Residual anatomic disease 4 (31) 2 (8) .16
Data are reported as number (%) or median (minimum - maximum). MSP, Multisite
perfusion; RCP, retrograde cerebral perfusion; CPB, cardiopulmonary bypass; NA,
not applicable. Missing data: *16%.
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Manomalies of fetal development, such as the kidney dysplasia
found in 2 patients undergoing MSP. In addition, a smaller
percentage of patients undergoing MSP were exposed to
preoperative nephrotoxins than those in the control group
(0% vs 33%). Despite the difference in nephrotoxin expo-
sure between the 2 groups, the preoperative eCCL in both
groups was 41 mL $ min1 $ 1.73 m2. The difference in
nephrotoxin exposure is explained by a recent shift away
from the use of gentamicin, in favor of other antibiotics,
while awaiting negative cultures in those neonates with
risk factors for infection.
Relevant intraoperative details are presented in Table 2.
There were no statistically significant differences in hemat-
ocrit nadir, peak plasma lactate concentration, urine output,
excessive bleeding, or rates of delayed sternal closure. Al-
though there were no differences in CPB or aortic cross-
clamp times, the median RCP time was shorter in the MSP
group than in controls (34 vs 43 minutes, respectively).
Intraoperative aprotinin infusions were used less fre-
quently in those undergoing MSP than in the control group
(0% vs 29%). In our institution, aprotinin was used rou-
tinely during operations in neonates with complex congeni-
tal heart disease until the release of a Food and Drug
Administration MedWatch alert in May of 2008 warned of
increased mortality rates after its use in adult cardiac sur-
gery. Inasmuch as aprotinin was no longer available as an
antifibrinolytic, the use of tranexamic acid increased, result-
ing in a statistically significant difference between groups 1
and 2 (92% vs 21%).
Although not reaching statistical significance, a higher
rate of residual anatomic disease after surgery was observed
in the group of patients undergoing MSP compared with
controls (31% vs 8%). In the MSP group, 2 patients had
moderate left-to-right shunting across residual complex api-
cal muscular VSDs and 2 had pulmonary artery stenoses re-
quiring combined balloon angioplasty and stent placement
on postoperative days 8 and 54. No patient in theMSP group
had recurrent aortic arch obstruction. Of the 2 patients with
residual disease in the control group, 1 had a residual mus-
cular VSD and the other had residual aortic arch obstruction
requiring balloon angioplasty. None of the residual VSDs
observed in this study required intervention.
Postoperative hemodynamic measurements (Table 3)
were similar in the 2 groups, although peak central venous
pressure on postoperative day 0 was higher in the group un-
dergoing MSP than in the control group (12 vs 11 mm Hg).
There were trends toward lower nadir mean arterial blood
pressure and a narrower difference between arterial and
mixed venous saturations in the MSP group on postopera-
tive days 2 and 3. There was also a trend toward more fre-
quent blood transfusions and a higher peak 72-hour
postoperative inotrope score in the MSP group compared
with the control group. Patients in the MSP group remained
in the cardiac intensive care unit for a longer period thanThe Journal of Thoracic and Cacontrols (9 vs 6 days). No patient in this study had necrotiz-
ing enterocolitis.
Postoperative renal function data are presented in Table 4.
The median decline in eCCL (using the postoperative nadir
eCCL) was 0% in the group undergoing MSP compared
with 29% in the group who underwent RCP alone
(P<.01). Similarly, the median decline in eCCL in the con-
trol group (using the postoperative mean eCCL) was 15%
compared with an increase of 15% in the group undergoing
MSP (P< .01). There was a trend toward both higher abso-
lute 72-hour postoperative nadir eCCL and 72-hour postop-
erative mean eCCL in the group undergoing MSP compared
with controls (37 vs 30 mL $ min1 $ 1.73 m2 and 48 vs 38
mL $ min1 $ 1.73 m2, respectively).
The threshold forAKIpostop nadir was reached in 8% (n¼ 1)
of those undergoing MSP and in 50% (n ¼ 12) of controls
(P ¼ .01). Although not reaching statistical significance,
none of the patients in the group undergoingMSPmet the cri-
teria for AKI when the 72-hour postoperative eCCL mean
was used to score forAKIpostop mean,whereas 25% in the con-
trol group did. Given the high rate of AKIpostop nadir in the
control group, we analyzed the rate of AKIpostop nadir in a sep-
arate cohort of 36 neonates undergoing repair of aortic arch
obstruction with VSD closure or a stage I Sano procedure
at our institution in 2003. Of the 37 neonates, 18 (49%)rdiovascular Surgery c Volume 140, Number 2 455
TABLE 3. Postoperative variables
Variable
MSP
(n ¼ 13)
RCP only
(n ¼ 24) P value
Nephrotoxin exposure
(within 72 h)
1 (8) 1 (4) 1.0
Blood transfusion
(within 72 h)
12 (92) 15 (63) .07
Re-exploration (within 72 h) 3 (23) 5 (21) 1.0
Necrotizing enterocolitis 0 (0) 0 (0) 1.0
Peak 72-h plasma
lactate (mmol/L)
6.5 (2.7–12.6) 5.8 (2.7–12.0) .55
Peak 72-h inotrope score 15 (8–20) 12.5 (5–28) .11
No. of diuretics
Day 0 0 (0–1) 0 (0–1) .66
Day 1 1 (0–1) 1 (0–2) .89
Day 2 1 (1–2) 1 (1–2) .80
Day 3 2 (1–2) 1 (1–2) .23
MAP nadir (mm Hg)
Day 0 43 (32–52) 45 (31–62) .81
Day 1 45 (31–49) 43 (33–62) .96
Day 2 41 (35–50) 47 (34–58) .08
Day 3 44 (28–50) 47 (35–56) .09
CVP peak (mm Hg)
Day 0* 12 (11–17) 11 (9–16) .02
Day 1 13 (9–18) 13 (7–20) .17
Day 2* 13 (8–15) 13 (7–16) .31
Day 3y 12 (8–15) 11 (8–14) 1.0
Peak AVO2 saturation
difference
Day 0z 37 (28–50) 35 (25–50) .54
Day 1x 37 (22–43) 34 (12–53) .75
Day 2k 25 (24–30) 28 (22–40) .08
Day 3{ 26 (21–30) 34 (16–40) .06
Net daily
fluid balance (mL/kg)
Day 1 9 (71 to 117) 37 (117 to 71) .05
Day 2 63 (133 to 32) 55 (275 to 40) .78
Day 3# 67 (191 to4) 44 (112 to 34) .31
Time to (d):
Chest closure 3 (0–7) 1 (0–7) .08
Enteral feeds 4 (2–10) 3 (1–9) .07
Extubation 6 (1–46) 4 (1–14) .06
ICU discharge 9 (4–139) 6 (3–24) .05
Data are reported as number (%) or median (minimum–maximum). Missing data:
*3%, y11%, z49%, x38%, k57%, {62%, #5%.MSP,Multisite perfusion; RCP, ret-
rograde cerebral perfusion; MAP, mean arterial blood pressure; CVP, central venous
pressure; AVO2, arteriovenous oxygen; ICU, intensive care unit.
TABLE 4. Renal function outcomes
Variable
MSP
(n ¼ 13)
RCP only
(n ¼ 24)
P
value
Urine output
(mL $ kg1 $ h1)
Day 1 3.8 (0.7–6.5) 4.6 (1.0–9.1) .15
Day 2 7.5 (2.8–9.4) 6.2 (2.5–16.7) .62
Day 3 7.1 (3.7–10.3) 5.4 (2.7–9.9) .28
Nadir 72-hour postop eCCL
(mL $ min1 $ 1.73 m2)
37 (28–75) 30 (20–57) .10
Mean 72-hour postop eCCL
(mL $ min1 $ 1.73 m2)
48 (29–75) 38 (25–65) .15
AKIpostop nadir* 1 (8) 12 (50) .01
AKIpostop meany 0 (0) 6 (25) .07
eCCL changepostop nadir (%)* 0 (33 to 60) 29 (50 to 14) <.01
eCCL changepostop mean (%)y 15 (18 to 64) 15 (38 to 42) <.01
Data are reported as number (%) or median (minimum–maximum). MSP, Multisite
perfusion; RCP, retrograde cerebral perfusion; eCCL, estimated creatinine clearance;
AKI, acute kidney injury. *(nadir postop eCCLpreop eCCL)/preop eCCL. y(mean
postop eCCLpreop eCCL)/preop eCCL.
TABLE 5. Subgroup analysis of renal function outcomes
Variable
MSP
(n ¼ 13)
RCP only
(n ¼ 11) P value
Urine output
(mL $ kg1 $ h1)
Day 1 3.8 (0.7–6.5) 3.6 (1.0–9.1) .96
Day 2 7.5 (2.8–9.4) 6.6 (2.5–16.7) .87
Day 3 7.1 (3.7–0.3) 6.8 (2.8–8.1) .53
Nadir 72 hour postoperative
eCCL (ml/min/1.73m2)
37 (28–75) 26 (20–41) <.01
Mean 72 hour
postoperative eCCL
(mL $ min1 $ 1.73 m2)
48 (29–75) 30 (27–49) .02
AKIpostop nadir* 1 (8) 7 (64) <.01
AKIpostop meany 0 (0) 2 (18) .20
eCCL changepostop nadir (%)* 0 (33 to 60) 33 (50 to 14) <.01
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Mmet the criteria for AKIpostop nadir. Similarly, given the
skewed exposure to, and potential effects of aprotinin and
preoperative nephrotoxins on changes in renal function, sep-
arate analyses were repeated after excluding those who re-
ceived each of these and the results were similar (Table 5).eCCL changepostop mean (%)y 15 (18 to 64) 14 (38 to 42) <.01
Data are reported as number (%) or median (minimum–maximum). MSP, Multisite
perfusion; RCP, retrograde cerebral perfusion; eCCL, estimated creatinine clearance;
AKI, acute kidney injury. *(nadir postop eCCLpreop eCCL)/preop eCCL. y(mean
postop eCCLpreop eCCL)/preop eCCL.DISCUSSION
Over the past 3 decades, dramatic advances in surgical
technique, CPB technology, and postoperative management456 The Journal of Thoracic and Cardiovascular Surghave resulted in a substantial decrease in mortality and mor-
bidity rates after surgery for congenital heart disease in neo-
nates. Despite this, morbidity related to end-organ
dysfunction resulting from inflammation and ischemia–re-
perfusion injury remains a significant problem. We devel-
oped a simple technique to improve visceral perfusion and
tested the hypothesis that, compared with upper body re-
gional perfusion alone, MSP with moderate or deep hypo-
thermia is associated with decreased postoperative AKI in
neonates undergoing reconstruction of the aortic arch.
Yasui and associates3 have also described a technique to
provide regional visceral perfusion during repair of interrupted
aortic arch. Their technique involved a separate leftery c August 2010
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Manterolateral thoracotomy and mobilization of the descending
aorta with subsequent end-to-side anastomosis of a polytetra-
fluoroethylene tube graft. A Y connection was then made in
the arterial limb of the bypass circuit, allowing simultaneous
perfusion to the ascending and descending aorta. The same
group modified this technique for use in patients undergoing
the Norwood procedure. The descending aorta was accessed
with an angled metal cannula via an incision in the posterior
pericardium at the level of the diaphragm.15 A similar tech-
nique was also used by Sano and colleagues16 in patients un-
dergoing modified stage I Norwood procedures. These
previous studies have described techniques of regional visceral
perfusion, but have not assessed the effect of lower body per-
fusion on the function of the kidneys or other abdominal vis-
cera.
This study demonstrates a significantly lower incidence
of AKI after neonatal aortic arch reconstructions performed
with MSP compared with recent results in a control group
undergoing repair with RCP only. This finding substanti-
ates the theory that providing direct abdominal perfusion
during neonatal aortic arch surgery ameliorates the renal in-
sult imposed by ischemia and reperfusion. The high preva-
lence of AKI identified in the control arm of this study and
the burgeoning data suggesting the important contribution
of renal dysfunction to postoperative morbidity and mortal-
ity after cardiac surgery reinforce the importance of this
issue.2,17-19
Importantly, we did not observe any complications that
could be directly attributed to the use of this new technique.
There were no clinically apparent blood vessel injuries in
those who underwent visceral perfusion. We did, however,
find that there was a more protracted postoperative course
in the group of patients undergoing MSP as evidenced by
a longer length of stay in the cardiac intensive care unit.
This finding is difficult to explain, but it may relate to the
substantially higher prevalence of preoperative comorbid-
ities in the MSP group. Both genetic syndromes and struc-
tural malformations are widely known risk factors for
prolonged recovery after surgery for congenital heart disease
in neonates.20-22
There are several important limitations to this study. In
addition to those mentioned earlier, there were other differ-
ences between the group undergoing MSP and those under-
going RCP alone. Patients in the control group were exposed
to preoperative nephrotoxins and intraoperative aprotonin
more frequently and had longer cerebral perfusion times. In-
asmuch as this was not a randomized, controlled trial, our
cases and controls were not ideally matched, leaving open
the possibility of confounding by these or unrecognized fac-
tors. The small sample size of this study precluded logistic
regression modeling to control for such potential con-
founders.
Because intraoperative and postoperative management
are constantly evolving and improving, it is possible thatThe Journal of Thoracic and Cathe selection of historic, although recent, controls resulted
in high baseline AKI rates, thereby exaggerating the differ-
ence between the 2 groups. It is also possible that subtle dif-
ferences in regional perfusion techniques used by the
attending surgeon influenced the primary outcome inasmuch
as the patients in the control group were operated on by 4 dif-
ferent staff surgeons, whereas only 2 of them operated on the
13 patients undergoing MSP. During this pilot study, we did
not systematically measure several important variables in-
cluding intraoperative and postoperative renal near-
infrared spectroscopy, flow through the femoral or umbilical
artery catheters, hepatic enzyme concentrations, urinary bio-
markers of AKI, and intraoperative gastric mucosal carbon
dioxide tension as a marker of mucosal perfusion.
In conclusion, we used a simple technique to provide si-
multaneous regional cerebral and visceral perfusion during
neonatal aortic arch reconstruction in an attempt to amelio-
rate renal injury. We found a significant decrease in the
rate of AKI in those undergoing MSP compared with that
in control patients in whom RCP alone was used. Despite
the limitations of this study, this is a promising and simple
technique that warrants further investigation.References
1. Toth-Heyn P, Drukker A, Guignard JP. The stressed neonatal kidney: from path-
ophysiology to clinical management of neonatal vasomotor nephropathy. Pediatr
Nephrol. 2000;14:227-39.
2. Baskin E, Saygili A, Harmanci K, Agras PI, Ozdemir FN, Mercan S, et al. Acute
renal failure and mortality after open-heart surgery in infants. Ren Fail. 2005;27:
557-60.
3. Yasui H, Kado H, Yonenaga K, Kawasaki S, Shiokawa Y, Kouno H, et al.
Revised technique of cardiopulmonary bypass in one-stage repair of interrupted
aortic arch complex. Ann Thorac Surg. 1993;55:1166-71.
4. Pigula FA, Nemoto EM, Griffith BP, Siewers RD. Regional low-flow perfusion
provides cerebral circulatory support during neonatal aortic arch reconstruction.
J Thorac Cardiovasc Surg. 2000;119:331-9.
5. Newburger JW, Jonas RA, Wernovsky G, Wypij D, Hickey PR, Kuban KC, et al.
A comparison of the perioperative neurologic effects of hypothermic circulatory
arrest versus low-flow cardiopulmonary bypass in infant heart surgery. N Engl J
Med. 1993;329:1057-64.
6. Dittrich S, Priesemann M, Fischer T, Boettcher W, Muller C, Alexi-
Meskishvili V, et al. Circulatory arrest and renal function in open-heart surgery
on infants. Pediatr Cardiol. 2002;23:15-9.
7. Asfour B, Bruker B, Kehl HG, Frund S, Scheld HH. Renal insufficiency in neo-
nates after cardiac surgery. Clin Nephrol. 1996;46:59-63.
8. Arnaoutakis GJ, Bihorac A, Martin TD, Hess PJ Jr, Klodell CT, Ejaz AA, et al.
RIFLE criteria for acute kidney injury in aortic arch surgery. J Thorac Cardiovasc
Surg. 2007;134:1554-60; discussion 60-1.
9. Pigula FA, Gandhi SK, Siewers RD, Davis PJ, Webber SA, Nemoto EM.
Regional low-flow perfusion provides somatic circulatory support during neona-
tal aortic arch surgery. Ann Thorac Surg. 2001;72:401-6; discussion 6-7.
10. Akcan-Arikan A, Zappitelli M, Loftis LL, Washburn KK, Jefferson LS,
Goldstein SL. Modified RIFLE criteria in critically ill children with acute kidney
injury. Kidney Int. 2007;71:1028-35.
11. Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A. A simple estimate of glo-
merular filtration rate in children derived from body length and plasma creatinine.
Pediatrics. 1976;58:259-63.
12. Brion LP, Fleischman AR, McCarton C, Schwartz GJ. A simple estimate of glo-
merular filtration rate in low birth weight infants during the first year of life: non-
invasive assessment of body composition and growth. J Pediatr. 1986;109:
698-707.
13. Welke KF, Dearani JA, Ghanayem NS, Beland MJ, Shen I, Ebels T. Renal com-
plications associated with the treatment of patients with congenital cardiacrdiovascular Surgery c Volume 140, Number 2 457
Perioperative Management Rajagopal et al
P
Mdisease: consensus definitions from the Multi-Societal Database Committee
for Pediatric and Congenital Heart Disease. Cardiol Young. 2008;18(Suppl. 2):
222-5.
14. Mou SS, Giroir BP, Molitor-Kirsch EA, Leonard SR, Nikaidoh H, Nizzi F, et al.
Fresh whole blood versus reconstituted blood for pump priming in heart surgery in
infants. N Engl J Med. 2004;351:1635-44.
15. Imoto Y, Kado H, Shiokawa Y, Fukae K, Yasui H. Norwood procedure without
circulatory arrest. Ann Thorac Surg. 1999;68:559-61.
16. Sano S, Ishino K, Kado H, Shiokawa Y, Sakamoto K, Yokota M, et al. Outcome
of right ventricle–to–pulmonary artery shunt in first-stage palliation of hypoplastic
left heart syndrome: a multi-institutional study. Ann Thorac Surg. 2004;78:
1951-7; discussion 7-8.
17. Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J. Independent as-
sociation between acute renal failure and mortality following cardiac surgery. Am
J Med. 1998;104:343-8.458 The Journal of Thoracic and Cardiovascular Surg18. Lassnigg A, Schmid ER, Hiesmayr M, Falk C, Druml W, Bauer P, et al. Impact of
minimal increases in serum creatinine on outcome in patients after cardiothoracic
surgery: do we have to revise current definitions of acute renal failure? Crit Care
Med. 2008;36:1129-37.
19. Rosner MH, Okusa MD. Acute kidney injury associated with cardiac surgery.
Clin J Am Soc Nephrol. 2006;1:19-32.
20. Silberbach M, Shumaker D, Menashe V, Cobanoglu A, Morris C. Predicting hos-
pital charge and length of stay for congenital heart disease surgery. Am J Cardiol.
1993;72:958-63.
21. Simsic JM, Coleman K, Maher KO, Cuadrado A, Kirshbom PM. Do neonates
with genetic abnormalities have an increased morbidity and mortality following
cardiac surgery? Congenit Heart Dis. 2009;4:160-5.
22. Stasik CN, Gelehrter S, Goldberg CS, Bove EL, Devaney EJ, Ohye RG. Current
outcomes and risk factors for the Norwood procedure. J Thorac Cardiovasc Surg.
2006;131:412-7.ery c August 2010
